These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23918904)
1. The DNA methyl transferase inhibitor, 5'-aza-2-deoxycitidine, enhances the apoptotic effect of Mevastatin in human leukemia HL-60 cells. Yilmaz A; Menevse S; Konac E; Alp E Hum Exp Toxicol; 2014 Apr; 33(4):414-23. PubMed ID: 23918904 [TBL] [Abstract][Full Text] [Related]
2. Effect of cytarabine and decitabine in combination in human leukemic cell lines. Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552 [TBL] [Abstract][Full Text] [Related]
3. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells]. Huang YY; Xia Y; Guo HX; Li WY Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):204-8. PubMed ID: 18250043 [TBL] [Abstract][Full Text] [Related]
4. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15. Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906 [TBL] [Abstract][Full Text] [Related]
5. Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid. Yang H; Hoshino K; Sanchez-Gonzalez B; Kantarjian H; Garcia-Manero G Leuk Res; 2005 Jul; 29(7):739-48. PubMed ID: 15927669 [TBL] [Abstract][Full Text] [Related]
6. 5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells. Wang L; Zhang Y; Li R; Chen Y; Pan X; Li G; Dai F; Yang J Cancer Biother Radiopharm; 2013 Feb; 28(1):34-44. PubMed ID: 22917213 [TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Zhu WG; Lakshmanan RR; Beal MD; Otterson GA Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429 [TBL] [Abstract][Full Text] [Related]
8. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells. Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863 [TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors. Morita S; Iida S; Kato K; Takagi Y; Uetake H; Sugihara K Oncology; 2006; 71(5-6):437-45. PubMed ID: 17690560 [TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. Bai T; Tanaka T; Yukawa K; Umesaki N Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806 [TBL] [Abstract][Full Text] [Related]
11. Effects of DNA methylation inhibitor on down-regulation of ribonuclease inhibitor expression in cancer cell lines. Chen JX; Fu PF; Wang T; Cui XY Ai Zheng; 2004 Nov; 23(11):1249-56. PubMed ID: 15522168 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Kozar K; Kamiński R; Switaj T; Ołdak T; Machaj E; Wysocki PJ; Mackiewicz A; Lasek W; Jakóbisiak M; Gołab J Clin Cancer Res; 2003 Aug; 9(8):3124-33. PubMed ID: 12912964 [TBL] [Abstract][Full Text] [Related]
13. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells. Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272 [TBL] [Abstract][Full Text] [Related]
14. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913 [TBL] [Abstract][Full Text] [Related]
15. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line. Liu X; Dai X; Wu B Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by bleomycin in p53-null HL-60 leukemia cells. Gimonet D; Landais E; Bobichon H; Coninx P; Liautaud-Roger F Int J Oncol; 2004 Feb; 24(2):313-9. PubMed ID: 14719107 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of in vitro anti-leukemia effect of 5-aza-2'-deoxycitydine]. Xiao YH; Yi H; Tan T; Liang T; Chen ZC; Xiao ZQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):344-52. PubMed ID: 18460780 [TBL] [Abstract][Full Text] [Related]
20. Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines. Tsujioka T; Yokoi A; Uesugi M; Kishimoto M; Tochigi A; Suemori S; Tohyama Y; Tohyama K Exp Hematol; 2013 Feb; 41(2):189-97. PubMed ID: 23085465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]